Why the study?
Cardiovascular-kidney-metabolic syndrome may predispose patients to coronary microvascular dysfunction through systemic microvascular injury, prompting investigation into accessible biomarkers for its identification.
Does the integration of accessible biomarkers like BNP and casual blood glucose improve the identification of coronary flow reserve impairment in patients without functional epicardial ischemia?
Does the integration of accessible biomarkers like BNP and casual blood glucose improve the identification of coronary flow reserve impairment in patients without functional epicardial ischemia?
Answers are grounded in this paper and cite their sources.
Readily accessible biomarkers, specifically the combination of BNP and casual blood glucose, provide a practical approach to identify patients at risk for coronary microvascular dysfunction within the cardiovascular-kidney-metabolic syndrome framework.
Cardiovascular-kidney-metabolic (CKM) syndrome may predispose patients to coronary microvascular dysfunction (CMD) through systemic microvascular injury. We investigated the association between CKM risk factors and CMD, focusing on the diagnostic performance of accessible biomarkers. In this exploratory analysis, we retrospectively analyzed 65 patients who underwent invasive coronary physiological assessment with thermodilution-derived coronary flow reserve (CFR) and index of microcirculatory resistance (IMR). Clinical variables included casual blood glucose, B-type natriuretic peptide (BNP), and the urine albumin-to-creatinine ratio (ACR), along with echocardiographic indices of diastolic function. Among the 65 patients, 20 (31 %) had impaired CFR. BNP (AUC = 0.74; 95 % confidence interval, CI, 0.60–0.88) and casual blood glucose (area under the curve, AUC = 0.64; 95 % CI, 0.49–0.80) showed diagnostic accuracy for impaired CFR of <2.0, while ACR improved model performance when combined with BNP or E/e′. The combination of BNP and casual glucose significantly improved diagnostic performance compared with either marker alone (AUC = 0.83 vs. 0.75; 95 % CI, 0.73–0.93; p = 0.03). The elevated BNP (AUC = 0.77, 95 % CI: 0.59–0.95) and higher ACR (AUC = 0.71, 95 % CI: 0.52–0.90) were significantly associated with structural CMD defined as CFR < 2.0 and IMR ≥ 25, whereas casual blood glucose was not. From a CKM perspective, BNP and casual blood glucose were associated with impairment of CFR and may serve as simple, accessible biomarkers for its early detection and risk stratification.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: